Gemeinschaftspraxis Ruhr – Praxis Überruhr
- Address
- Schaffelhofer Weg 10, 45277 Essen, Germany
Gemeinschaftspraxis Ruhr – Praxis Überruhr: Cardiovascular and Lipid Disorder Research
Gemeinschaftspraxis Ruhr – Praxis Überruhr is a clinical research practice specializing in advanced cardiovascular disease prevention and lipid metabolism disorders. The center focuses on evaluating innovative therapeutic approaches for patients with elevated cholesterol and cardiovascular risk, participating in pivotal multinational trials that assess novel lipid-lowering interventions and their impact on major cardiovascular outcomes.
- Hypercholesterolemia management with next-generation therapies including inclisiran
- Lipoprotein(a) reduction strategies for cardiovascular disease prevention
- Major adverse cardiovascular event (MACE) reduction in high-risk populations
The practice contributes to critical research investigating targeted approaches beyond traditional statin therapy, including studies of inclisiran for LDL-cholesterol reduction and pelacarsen (TQJ230) for lipoprotein(a) lowering. These trials evaluate both the efficacy of achieving individualized cholesterol targets and the potential to reduce cardiovascular death, myocardial infarction, stroke, and urgent coronary revascularization in patients with established cardiovascular disease and elevated lipoprotein levels.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novartis Pharma AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gemeinschaftspraxis Ruhr – Praxis Überruhr
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Pelacarsen (TQJ230) in Reducing Major Cardiovascular Events in Patients with Established Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial | Novartis Pharma AG | Phase III | Not Recruiting | Mar 2020 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pelacarsen | 2 | Unknown | 2020-03-06 | 2026-05-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.